Viela Bio is based in Gaithersburg, Maryland. It has raised $300M in total funding. Latest round: Series B.
Viela Bio funding overview
Viela Bio is based in Gaithersburg, Maryland. Viela Bio has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in June 2019. The round record for Viela Bio runs through 2019; nothing later has been disclosed. Investors on record include HBM Healthcare Investments, Viking Global Investors, Cormorant Asset Management, Terra Magnum Capital Partners, Goldman Sachs, Barer & Son Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Viela Bio at a glance
Total raised
$300M
Latest round
Series B
Latest round date
June 2019
Headquarters
Gaithersburg, Maryland
Notable investors
HBM Healthcare Investments, Viking Global Investors, Cormorant Asset Management, Terra Magnum Capital Partners, Goldman Sachs, Barer & Son Capital, Temasek
Frequently asked about Viela Bio funding
How much has Viela Bio raised?
Viela Bio has raised $300M in total disclosed funding across the rounds on record.
Who has invested in Viela Bio?
HBM Healthcare Investments, Viking Global Investors, Cormorant Asset Management, Terra Magnum Capital Partners, Goldman Sachs, Barer & Son Capital are named among the investors backing Viela Bio.
What was the latest Viela Bio funding round?
The most recent disclosed round is a Series B, announced in June 2019.
Where is Viela Bio based?
Viela Bio is based in Gaithersburg, Maryland.
When did Viela Bio last raise?
The last disclosed Viela Bio round closed in June 2019 at Series B.
Viela Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Gaithersburg below to benchmark round size and investor mix.
